{"nct_id":"NCT05954143","title":"Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2023-11-30","start_date_type":"ACTUAL","primary_completion_date":"2024-09-20","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BOLT"]}